Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration
Background: Neurodegenerative diseases are incurable disorders caused by progressive neuronal cell death. Retinitis pigmentosa (RP) is a blinding neurodegenerative disease that results in photoreceptor death and progresses to the loss of the entire retinal network. We previously found that proteomic...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-02-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396420300116 |
id |
doaj-9faaee8086dc409cadd8ba21adb03d1e |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Katherine J. Wert Gabriel Velez Vijaya L. Kanchustambham Vishnu Shankar Lucy P. Evans Jesse D. Sengillo Richard N. Zare Alexander G. Bassuk Stephen H. Tsang Vinit B. Mahajan |
spellingShingle |
Katherine J. Wert Gabriel Velez Vijaya L. Kanchustambham Vishnu Shankar Lucy P. Evans Jesse D. Sengillo Richard N. Zare Alexander G. Bassuk Stephen H. Tsang Vinit B. Mahajan Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration EBioMedicine |
author_facet |
Katherine J. Wert Gabriel Velez Vijaya L. Kanchustambham Vishnu Shankar Lucy P. Evans Jesse D. Sengillo Richard N. Zare Alexander G. Bassuk Stephen H. Tsang Vinit B. Mahajan |
author_sort |
Katherine J. Wert |
title |
Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration |
title_short |
Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration |
title_full |
Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration |
title_fullStr |
Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration |
title_full_unstemmed |
Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration |
title_sort |
metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration |
publisher |
Elsevier |
series |
EBioMedicine |
issn |
2352-3964 |
publishDate |
2020-02-01 |
description |
Background: Neurodegenerative diseases are incurable disorders caused by progressive neuronal cell death. Retinitis pigmentosa (RP) is a blinding neurodegenerative disease that results in photoreceptor death and progresses to the loss of the entire retinal network. We previously found that proteomic analysis of the adjacent vitreous served as way to indirectly biopsy the retina and identify changes in the retinal proteome. Methods: We analyzed protein expression in liquid vitreous biopsies from autosomal recessive (ar)RP patients with PDE6A mutations and arRP mice with Pde6ɑ mutations. Proteomic analysis of retina and vitreous samples identified molecular pathways affected at the onset of photoreceptor death. Based on affected molecular pathways, arRP mice were treated with a ketogenic diet or metabolites involved in fatty-acid synthesis, oxidative phosphorylation, and the tricarboxylic acid (TCA) cycle. Findings: Dietary supplementation of a single metabolite, ɑ-ketoglutarate, increased docosahexaeonic acid levels, provided neuroprotection, and enhanced visual function in arRP mice. A ketogenic diet delayed photoreceptor cell loss, while vitamin B supplementation had a limited effect. Finally, desorption electrospray ionization mass spectrometry imaging (DESI-MSI) on ɑ-ketoglutarate-treated mice revealed restoration of metabolites that correlated with our proteomic findings: uridine, dihydrouridine, and thymidine (pyrimidine and purine metabolism), glutamine and glutamate (glutamine/glutamate conversion), and succinic and aconitic acid (TCA cycle). Interpretation: This study demonstrates that replenishing TCA cycle metabolites via oral supplementation prolongs retinal function and provides a neuroprotective effect on the photoreceptor cells and inner retinal network. Funding: NIH grants [R01EY026682, R01EY024665, R01EY025225, R01EY024698, R21AG050437, P30EY026877, 5P30EY019007, R01EY018213, F30EYE027986, T32GM007337, 5P30CA013696], NSF grant CHE-1734082. Keywords: Metabolomics, Metabolite supplementation, TCA cycle, Ketogenic diet, ɑ-ketoglutarate, Desorption electrospray ionization mass spectrometry |
url |
http://www.sciencedirect.com/science/article/pii/S2352396420300116 |
work_keys_str_mv |
AT katherinejwert metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration AT gabrielvelez metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration AT vijayalkanchustambham metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration AT vishnushankar metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration AT lucypevans metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration AT jessedsengillo metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration AT richardnzare metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration AT alexandergbassuk metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration AT stephenhtsang metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration AT vinitbmahajan metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration |
_version_ |
1725077489964810240 |
spelling |
doaj-9faaee8086dc409cadd8ba21adb03d1e2020-11-25T01:33:24ZengElsevierEBioMedicine2352-39642020-02-0152Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegenerationKatherine J. Wert0Gabriel Velez1Vijaya L. Kanchustambham2Vishnu Shankar3Lucy P. Evans4Jesse D. Sengillo5Richard N. Zare6Alexander G. Bassuk7Stephen H. Tsang8Vinit B. Mahajan9Omics Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, United StatesOmics Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, United States; Medical Scientist Training Program, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United StatesDepartment of Chemistry, Stanford University, Stanford, CA 94305, United StatesDepartment of Chemistry, Stanford University, Stanford, CA 94305, United StatesDepartments of Pediatrics and Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United StatesBascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL 33136, United StatesDepartment of Chemistry, Stanford University, Stanford, CA 94305, United StatesDepartments of Pediatrics and Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United StatesEdward S. Harkness Eye Institute, New York-Presbyterian Hospital, New York, NY 10032, United States; Jonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Department of Ophthalmology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, United States; Department of Pathology & Cell Biology, Stem Cell Initiative (CSCI), Institute of Human Nutrition, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, United StatesOmics Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, United States; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, United States; Corresponding author at: Omics Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, United States.Background: Neurodegenerative diseases are incurable disorders caused by progressive neuronal cell death. Retinitis pigmentosa (RP) is a blinding neurodegenerative disease that results in photoreceptor death and progresses to the loss of the entire retinal network. We previously found that proteomic analysis of the adjacent vitreous served as way to indirectly biopsy the retina and identify changes in the retinal proteome. Methods: We analyzed protein expression in liquid vitreous biopsies from autosomal recessive (ar)RP patients with PDE6A mutations and arRP mice with Pde6ɑ mutations. Proteomic analysis of retina and vitreous samples identified molecular pathways affected at the onset of photoreceptor death. Based on affected molecular pathways, arRP mice were treated with a ketogenic diet or metabolites involved in fatty-acid synthesis, oxidative phosphorylation, and the tricarboxylic acid (TCA) cycle. Findings: Dietary supplementation of a single metabolite, ɑ-ketoglutarate, increased docosahexaeonic acid levels, provided neuroprotection, and enhanced visual function in arRP mice. A ketogenic diet delayed photoreceptor cell loss, while vitamin B supplementation had a limited effect. Finally, desorption electrospray ionization mass spectrometry imaging (DESI-MSI) on ɑ-ketoglutarate-treated mice revealed restoration of metabolites that correlated with our proteomic findings: uridine, dihydrouridine, and thymidine (pyrimidine and purine metabolism), glutamine and glutamate (glutamine/glutamate conversion), and succinic and aconitic acid (TCA cycle). Interpretation: This study demonstrates that replenishing TCA cycle metabolites via oral supplementation prolongs retinal function and provides a neuroprotective effect on the photoreceptor cells and inner retinal network. Funding: NIH grants [R01EY026682, R01EY024665, R01EY025225, R01EY024698, R21AG050437, P30EY026877, 5P30EY019007, R01EY018213, F30EYE027986, T32GM007337, 5P30CA013696], NSF grant CHE-1734082. Keywords: Metabolomics, Metabolite supplementation, TCA cycle, Ketogenic diet, ɑ-ketoglutarate, Desorption electrospray ionization mass spectrometryhttp://www.sciencedirect.com/science/article/pii/S2352396420300116 |